Replies to post #957 on Endra Life Sciences Inc (NDRA)

[dndodd]

As is most all of micro bio tech

[oldgrowth28]

On 2/28, Cantor Fitzgerald initiated coverage on Hepion with an Overweight rating and an initial price target of $3.50. Also, Hepion has substantial cash reserves and is generating revenue.
NDRA